CLINICAL_TRIALS
trial_result
· 2021-10-20
Clinical Trial Update: Evaluation of Dupilumab in Children With Uncontrolled Asthma [Phase 3]
Summary
Phase 3 trial evaluating dupilumab in children with uncontrolled asthma has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-10-20